BTA 0.00% 57.0¢ biota holdings limited

If this report is correct then GSK are in talks to expand...

  1. 53 Posts.
    If this report is correct then GSK are in talks to expand production of Relenza with Nicholas Piramal India . One would expect that this means they have commitments for the medication .

    I am a holder of BTA

    http://www.expresspharmapulse.com/20051215/market08.shtml
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.